Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

Business / Technology


Our network sites seattletimes.com | Advanced

Originally published December 14, 2009 at 8:16 AM | Page modified December 14, 2009 at 11:31 AM

Comments (0)     E-mail E-mail article      Print Print      Share Share

ZymoGenetics partner Bayer halts EU effort on drug

Bayer has withdrawn its application to market the ZymoGenetics drug Recothrom in Europe, the Seattle-based biotechnology company said Monday.

Bayer, which has exclusive rights to market Recothrom outside the United States, concluded the drug was unlikely to get approved without additional clinical trial data, ZymoGenetics said.

E-mail E-mail article      Print Print      Share Share

More Business & Technology

UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case

UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip

UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award

UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall

NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook

More Business & Technology headlines...

Comments
No comments have been posted to this article.

advertising


Get home delivery today!

Video

Advertising

AP Video

Entertainment | Top Video | World | Offbeat Video | Sci-Tech

Marketplace

 
Most read
Most commented
Most e-mailed
 
 

Most viewed imagesMore

Advertising